Point72 Asset Management, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (OLMA)

Filing manager
Point72 Asset Management, L.P.
Reporting owner
Point72 Asset Management, L.P.
Security
Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Beneficially owned shares
1,543,931 shares
Ownership signal 1 fact
Class ownership
2.3%
Subject security 2 facts
Symbol
OLMA
Shares outstanding
67,127,435 shares
SEC evidence 4 facts
Form type
SCHEDULE 13G/A
Accepted by SEC
15 May 2025, 15:51:30 UTC
Event date
31 Mar 2025
SEC filing
View on sec.gov

Key filing fact

Point72 Asset Management, L.P. disclosed 2.3% ownership in Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (OLMA) on 31 Mar 2025.

Key facts

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (OLMA).
  • Disclosed ownership: 2.3%.
  • Date of event: 31 Mar 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 15:51.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (3)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 2.3% 1,543,931 0 1,543,931 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 2.3% 1,543,931 0 1,543,931 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 2.3% 1,543,931 0 1,543,931 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .